| scholarly article | Q13442814 |
| P50 | author | Alexander J. Szalai | Q42706107 |
| P2093 | author name string | J Wu | |
| Y Ji | |||
| W P Fay | |||
| T L Strawn | |||
| A W Lohman | |||
| P M Fish | |||
| P2860 | cites work | Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo | Q24669536 |
| C-reactive protein: a critical update | Q24672855 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice | Q30967068 | ||
| Inducible and tissue-specific expression of human C-reactive protein in transgenic mice | Q33930080 | ||
| C-reactive protein-mediated vascular injury requires complement. | Q33961757 | ||
| C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells | Q34078577 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. | Q36357402 | ||
| C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta | Q36893296 | ||
| C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo | Q37114370 | ||
| C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy | Q40248704 | ||
| Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment | Q40769278 | ||
| Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
| Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation | Q41975370 | ||
| Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts | Q42128982 | ||
| C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. | Q46005836 | ||
| C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation | Q46603281 | ||
| C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction | Q46656237 | ||
| Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. | Q48032486 | ||
| Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study | Q48419507 | ||
| Macrophage depletion alters vein graft intimal hyperplasia. | Q53975070 | ||
| Vitronectin inhibits the thrombotic response to arterial injury in mice. | Q54459609 | ||
| Mechanisms of c-reactive protein up-regulation in arterialized vein grafts. | Q54619598 | ||
| The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts | Q68076723 | ||
| Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors | Q69965580 | ||
| C-reactive protein binding to murine leukocytes requires Fc gamma receptors | Q73368189 | ||
| Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations | Q73446460 | ||
| An ultrastructural study of progressive intimal hyperplasia in rat vein grafts | Q73551031 | ||
| Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue | Q73944158 | ||
| CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? | Q79399756 | ||
| C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis | Q79843344 | ||
| C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance | Q80706514 | ||
| Activation of inflammation and coagulation after infusion of C-reactive protein in humans | Q81538444 | ||
| Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy | Q83962396 | ||
| CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway | Q84290978 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1667-1677 | |
| P577 | publication date | 2014-08-23 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts | |
| P478 | volume | 12 |
| Q100512481 | An aberrant STAT pathway is central to COVID-19 |
| Q38801276 | Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection |
| Q47994855 | Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization |
| Q92445757 | The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease |
| Q92258061 | Vulnerable Plaque, Characteristics, Detection, and Potential Therapies |
Search more.